Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.

Ouellet H, Kells PM, Ortiz de Montellano PR, Podust LM.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):332-7. doi: 10.1016/j.bmcl.2010.11.007. Epub 2010 Nov 5.

2.

Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.

McLean KJ, Munro AW.

Drug Metab Rev. 2008;40(3):427-46. doi: 10.1080/03602530802186389 . Review.

PMID:
18642141
3.

Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.

Hudson SA, McLean KJ, Munro AW, Abell C.

Biochem Soc Trans. 2012 Jun 1;40(3):573-9. doi: 10.1042/BST20120062. Review.

PMID:
22616869
4.

[Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target].

Lu Y, Qiao F, You XF, Yang XY.

Yao Xue Xue Bao. 2014 Apr;49(4):427-34. Review. Chinese.

PMID:
24974457
5.

The Mycobacterium tuberculosis cytochrome P450 system.

Ouellet H, Johnston JB, Ortiz de Montellano PR.

Arch Biochem Biophys. 2010 Jan 1;493(1):82-95. doi: 10.1016/j.abb.2009.07.011. Epub 2009 Jul 25. Review.

6.

The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.

McLean KJ, Belcher J, Driscoll MD, Fernandez CC, Le Van D, Bui S, Golovanova M, Munro AW.

Future Med Chem. 2010 Aug;2(8):1339-53. doi: 10.4155/fmc.10.216. Review.

PMID:
21426022
8.
9.

Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems.

McLean KJ, Dunford AJ, Neeli R, Driscoll MD, Munro AW.

Arch Biochem Biophys. 2007 Aug 15;464(2):228-40. Epub 2007 Apr 10. Review.

PMID:
17482138

Supplemental Content

Support Center